TrialBreast cancer research : BCR2016

Safety and efficacy of vinorelbine in combination with pertuzumab and trastuzumab for first-line treatment of patients with HER2-positive locally advanced or metastatic breast cancer: VELVET Cohort 1 final results.

Edith A Perez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.